Antimicrobial susceptibility of clinical isolates of aerobic Gram-positive cocci and anaerobic bacteria in 2004

Japanese Journal of Chemotherapy

Volumn 56, Issue 5, 2008, Pages 543-561

  Fujimura, Takaji ^a   Yoshida, Isamu ^a   Itoh, Yoshihisa ^b   Tachibana, Mineji ^b   Kaku, Mitsuo ^c   Kanemitsu, Keiji ^d   Takahashi, Choichiro ^e   Shiotani, Joji ^b   Ono, Yuka ^b   Baba, Hisashi ^f   Matsuo, Shuji ^b   Asari, Seishi ^g   Matsuoka, Kimiko ^b   Kusano, Nobuchika ^h   Nose, Motoko ^h   Saikawa, Tetsunori ⁱ   Hiramatsu, Kazufumi ⁱ   Kohno, Shigeru ^j   Hirakata, Yoichi ^c   Yamane, Nobuhisa ^b   Nakasone, Isamu ^k   Yamano, Yoshinori ^a   more..

^a SHIONOGI AND CO LTD   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^e YAMAGATA UNIVERSITY HOSPITAL   (Japan)

^f NAGOYA UNIVERSITY HOSPITAL   (Japan)

^g OSAKA UNIVERSITY HOSPITAL   (Japan)

^h OKAYAMA UNIVERSITY HOSPITAL   (Japan)

ⁱ OITA UNIVERSITY HOSPITAL   (Japan)

^j NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^k UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

more..

Author keywords

Anaerobe; Clinical isolate; Drug susceptibility; Gram positive cocci; Surveillance

Indexed keywords

EID: 67650755669     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. th ed, American Society for Microbiology, Washington, DC, 2003
2. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing. Seventeenth informational supplement, M 100-S17, Clinical and Laboratory Standards Institute, Wayne, Pa. 2007
3. th ed., M7-A7, Clinical and Laboratory Standards Institute, Wayne, Pa. 2006
4. th ed., M11-A6, National Committee for Clinical Laboratory Standards, Wayne, Pa. 2004
5. Chemotherapy 1990; 38: 102-5
6. Ubukata K, Muraki T, Igarashi A, Asahi Y, Konno M: Working Group for Penicillin-Resistant S. pneumoniae: Identification of penicillin and other beta-lactam resistance in Streptococcus pneumoniae by polymerase chain reaction. J Infect Chemother 1997; 3: 190-7 (Pubitemid 127722509)
7. Jpn J Antibiotics 2004; 57: 196-203
8. Kirby J T, Fritsche T R, Jones R N: Influence of patient age on the frequency of occurrence and antimicrobial resistance patterns of isolates from hematology/oncology patient: Report from the Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance Program (North America). Diagn Microbiol Infect Dis 2006; 56: 75-82 (Pubitemid 44279946)
9. Fedler K A, Biedenbach D J, Jones R N: Assessment of pathogen frequency and resistance patterns among pediatric patient isolates: Report from the 2004 SENTRY Antimicrobial Surveillance Program on 3 continents. Diagn Microbiol Infect Dis 2006; 56: 427-36 (Pubitemid 44854360)
10. Moet G J, Jones R N, Biedenbach D J, Stilwell M J, Fritsche T R: Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis 2007; 57: 7-13 (Pubitemid 44908825)
11. Jpn J Antibiotics 2006; 59: 323-54
12. Jpn J Antibiotics 2005; 58: 231-58
13. Chang S, Sievert D M, Hageman J C, Boulton M L, Tenover F C, Downes F P, et al.: Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003; 348: 1342-7 (Pubitemid 36384101)
14. Tenover F C, Weigel L M, Appelbaum P C, McDougal L K, Chaitram J, McAllister S, et al.: Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother 2004; 48: 275-80 (Pubitemid 38040208)
15. Centers for Disease Control and Prevention: Vancomycin-resistant Staphylococcus aureus-New York, 2004-. Morb Mortal Wkly Rep 2004; 53: 322-3
16. Sánchez M, Vicente M F, Cercenado E, de Pedro M A, Gómez P, Moreno R, et al.: Diversity among clinical isolates of penicillin-resistant Streptococcus mitis: indication for a PBP1-dependent way to reach high level of penicillin resistance. Int Microbiol 2001; 4: 217-22 (Pubitemid 33771684)
17. Jpn J Antibiotics 2002; 55: 568-655
18. Jpn J Antibiotics 2006; 59: 177-200
19. Jpn J Antibiotics 2006; 59: 428-51
20. Jpn J Antibiotics 2007; 60: 59-97
21. Jpn J Antibiotics 2004; 57: 70-104
22. Sóki J, Edwards R, Hedberg M, Fang H, Nagy E, Nord C E, et al.: Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey. Int J Antimicrob Agents 2006; 28: 497-502 (Pubitemid 44794458)
23. Peláez T, Alcalá L, Alonso R, Rodríguez- Créixems M, García-Lechuz J M, Bouza E: Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin. Antimicrob Agents Chemother 2002; 46: 1647-50 (Pubitemid 34535177)